K. Molyneux

发表

Effect of Immunosuppressive Drugs on the Changes of Serum Galactose-Deficient IgA1 in Patients with IgA Nephropathy

J. Barratt, S. Schaub, S. Stampf, 2016, PloS one.

Higher serum galactose-deficient immunoglobulin A1 concentration is associated with stronger mesangial cellular inflammatory response and more severe histologic findings in immunoglobulin A nephropathy

F. Tam, K. König, H. Hopfer, 2018, Clinical kidney journal.

O-glycosylation of serum IgD in IgA nephropathy.

J. D. de Wolff, J. Barratt, J. Feehally, 2006, Journal of the American Society of Nephrology : JASN.

Immunopathogenesis of IgAN

J. Barratt, J. Feehally, Alice C. Smith, 2007, Seminars in Immunopathology.

O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy.

J. Barratt, J. Feehally, Alice C. Smith, 2006, Journal of the American Society of Nephrology : JASN.

B-cell O-galactosyltransferase activity, and expression of O-glycosylation genes in bone marrow in IgA nephropathy.

J. Barratt, J. Feehally, Alice C. Smith, 2008, Kidney international.

Galactose deficient IgA1 (GD-IgA1) in skin and serum from patients with skin-limited and systemic IgA Vasculitis.

Yusuke Suzuki, J. Barratt, C. Sunderkötter, 2019, Journal of the American Academy of Dermatology.

Spleen Tyrosine Kinase Is Important in the Production of Proinflammatory Cytokines and Cell Proliferation in Human Mesangial Cells following Stimulation with IgA1 Isolated from IgA Nephropathy Patients

J. Barratt, E. Masuda, C. Pusey, 2012, The Journal of Immunology.

Isolated from IgA Nephropathy Patients Cells following Stimulation with IgA1 and Cell Proliferation in Human Mesangial Production of Proinflammatory Cytokines Spleen Tyrosine Kinase Is Important in the

J. Barratt, E. Masuda, C. Pusey, 2012 .

Identification of β 1 , 4-galactosyltransferase 1 as a novel receptor for IgA in human mesangial cells

J. Barratt, J. Feehally, P. Mertens, 2018 .

β1,4-galactosyltransferase 1 is a novel receptor for IgA in human mesangial cells.

J. Barratt, J. Feehally, M. Muto, 2017, Kidney international.

Recurrence of IgA nephropathy after kidney transplantation: experience from the Swiss transplant cohort study

J. Barratt, T. Mueller, K. Hadaya, 2022, BMC Nephrology.

Lymphocyte responses to influenza and tetanus toxoid in vitro following intensive exercise and carbohydrate ingestion on consecutive days.

G. J. Walker, N. Bishop, Alice C. Smith, 2005, Journal of applied physiology.

changes in T-lymphocyte function Carbohydrate supplementation and exercise-induced

G. J. Walker, J. Davis, N. Bishop, 2015 .

A single amino acid deletion in the α2(I) chain of type I collagen produces osteogenesis imperfecta type III

P. Byers, R. Dalgleish, B. Starman, 1993, Human Genetics.

The molecular genetics of human collagen genes and osteogenesis imperfecta

K. Molyneux, 1991 .

The effect of citrate in drinks on plaque pH

R. J. Jackson, K. Molyneux, S. Duke, 1988, British Dental Journal.

An update on the pathogenesis and treatment of IgA nephropathy.

Jonathan Barratt, John Feehally, J. Barratt, 2012, Kidney international.

Differential expression of microRNA miR-150-5p in IgA nephropathy as a potential mediator and marker of disease progression.

Robert H. Jenkins, A. Didangelos, J. Saez-Rodriguez, 2021, Kidney international.

New Insights into the Pathogenesis and Treatment Strategies in IgA Nephropathy

J. Barratt, C. Cheung, H. Selvaskandan, 2021, Glomerular Diseases.

The solution structures of native and patient monomeric human IgA1 reveal asymmetric extended structures: implications for function and IgAN disease

J. Barratt, D. Wright, S. Perkins, 2015, The Biochemical journal.

Systemic Activation of Neutrophils by Immune Complexes Is Critical to IgA Vasculitis

J. Barratt, T. Vogl, J. Roth, 2022, The Journal of Immunology.

DogMap: an international collaboration toward a low-resolution canine genetic marker map. DogMap Consortium.

Merete Fredholm, Nicola Reimann, George Lubas, 1999, The Journal of heredity.

Galactosylation of IgA1 Is Associated with Common Variation in C1GALT1.

N. Samani, C. Nelson, D. Gale, 2017, Journal of the American Society of Nephrology : JASN.

Macrophage interactions with collecting duct epithelial cells are capable of driving tubulointerstitial inflammation and fibrosis in immunoglobulin A nephropathy.

J. Barratt, I. Roberts, I. Pawluczyk, 2020, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Abnormal IgD and IgA1 O-glycosylation in hyperimmunoglobulinaemia D and periodic fever syndrome

Stephen J. Dickinson, J. D. de Wolff, J. Barratt, 2009, Clinical and Experimental Medicine.

Combined walking exercise and alkali therapy in patients with CKD4–5 regulates intramuscular free amino acid pools and ubiquitin E3 ligase expression

S. Shirreffs, R. Maughan, J. Feehally, 2013, European Journal of Applied Physiology.

FC051: Atacicept Reduces Serum ANTI-GD-IGA1 Levels in IgAN Patients

Yusuke Suzuki, J. Barratt, K. Molyneux, 2022, Nephrology, Dialysis and Transplantation.

Is sialylation of IgA the agent provocateur of IgA nephropathy?

J. Barratt, J. Feehally, Alice C. Smith, 2008, Nephrology, Dialysis and Transplantation.

Immune and inflammatory mechanisms

J. Barratt, E. Masuda, T. Akizawa, 2011 .

Galactosylation of IgA1 Is Associated with Common Variation in C1GALT1.

N. Samani, D. Gale, J. Barratt, 2017, Journal of the American Society of Nephrology : JASN.

Combined walking exercise and alkali therapy in patients with CKD4–5 regulates intramuscular free amino acid pools and ubiquitin E3 ligase expression

S. Shirreffs, R. Maughan, J. Feehally, 2013, European Journal of Applied Physiology.

Targeted-release budesonide modifies key pathogenic biomarkers in immunoglobulin A nephropathy: Insights from the NEFIGAN trial.

D. Maixnerova, L. Pérez-Alós, C. Seikrit, 2023, Kidney international.